Changes in peripheral blood T-cell balance after percutaneous tumor ablation
Purpose: To evaluate the changes in T-cell balance in peripheral blood following percutaneous tumor ablation. Material and methods: Patients underwent thermal ablation including radiofrequency (n = 9) and microwave ablation (n = 5), or cryoablation (n = 5). Target tumors were located in the lung (n ...
Saved in:
Published in | Minimally invasive therapy and allied technologies Vol. 26; no. 6; pp. 331 - 337 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Taylor & Francis
02.11.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Purpose: To evaluate the changes in T-cell balance in peripheral blood following percutaneous tumor ablation.
Material and methods: Patients underwent thermal ablation including radiofrequency (n = 9) and microwave ablation (n = 5), or cryoablation (n = 5). Target tumors were located in the lung (n = 7), soft tissue (n = 5), liver (n = 4), and bone (n = 3). Patient peripheral blood samples were collected before and within 14 days after ablation. Peripheral blood populations of cytotoxic T-cells (CTL), type-1 (T
h
1) and type-2 helper T-cells (T
h
2), and regulatory T-cells (T
reg
) were measured using flow cytometry. Changes in CTL/T
reg
and T
h
1/T
h
2 ratios before and after ablation therapy were compared using paired t-tests.
Results: Peripheral blood CTL population (27.5 ± 2.1% to 30.2 ± 2.5%, p < .03) and CTL/T
reg
ratios (18.8 ± 3.7% to 21.6 ± 3.6%, p < .05) increased significantly after ablation. Although a significant increase in CTL/T
reg
ratios was found after heat-based ablation (18.0 ± 4.4% to 21.6 ± 4.7%, p < .02), it remained unchanged after cryoablation (21.0 ± 7.0% to 21.5 ± 4.3%, p = .92). T
h
1/T
h
2 ratio (13.7 ± 3.0% to 17.2 ± 3.5%, p = .12) remained unchanged after ablation.
Conclusion: Ablation therapy alters the T-cell balance by increasing the systemic CTL/T
reg,
ratio. Heat-based ablation might be a more effective approach than cryoablation to enhance systemic anti-tumor immunity. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1364-5706 1365-2931 1365-2931 |
DOI: | 10.1080/13645706.2017.1310737 |